Alliances
St Vincent’s Institute of Medical Research in Melbourne, Australia, announced the extension of the research and licensing collaboration agreement with Janssen Pharmaceuticals, Inc, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, with focus on Alzheimer’s disease treatment.
Kalos Therapeutics has engaged with The OCMX to assist in fund raising.
Combining the strengths of MAIN5 and Iperion Life Sciences Consultancy for the benefit of the European Pharmaceutical Industry.
The two companies struck a strategic collaboration and option agreement to harness the power of Immatics’ T-Cell Receptor Engineered T-cell Therapy programs and aim them at solid tumors.
Velabs Therapeutics announced that its cooperation with Chiome Bioscience, Inc., Tokyo, will be deepened, to jointly discover modulatory and functional antibodies for one of Chiome’s GPCR target genes.
Predictive Laboratories, a biotech company focused on genetic testing to understand human infertility and women’s health recently formed in 2017, is making an effort to speed up its research with a recently announced collaboration with Thermo Fisher Scientific, which is a major player in female infertility research.
Xylonix announced it has signed a Memorandum of Understanding (MOU) with BioGemex to jointly develop a new pre-treatment point-of-care diagnostic, XDX-01, to better predict a patient’s response to T-cell mediated cancer immunotherapies in solid tumors.
Research scientists representing Regenstrief Institute, Indiana University School of Medicine and IU Richard M. Fairbanks School of Public Health at IUPUI are joining – and in some cases leading – the global health conversation at the 17th World Congress of Medical and Health Informatics (MedInfo).
Under the terms of the deal, Utragenyx will pay GeneTx $20 million for an exclusive option to acquire GeneTx.
Ultragenyx Pharmaceutical Inc. and GeneTx Biotherapeutics LLC announced a partnership to develop GeneTx’s GTX-102, an antisense oligonucleotide (ASO) for the treatment of Angelman syndrome, a serious, debilitating, rare neurogenetic disorder that affects approximately 1 in 15,000 people worldwide.
PRESS RELEASES